I honestly find it quite sad that shareholders have to try and spread awareness about Cytodyn and Leronlimab. Don't get me wrong, I love the initiative, but it simply shouldn't be necessary.

Big Pharma sneezes and the whole world offers it a tissue. Cytodyn unveils trial results proving efficacy in the fight against a global pandemic and all we hear are crickets and watch our brokerage accounts slowly deflate in value.

It's imperative we uplist by the end of the month or early Sept.

Obviously EUA changes everything too. So fingers crossed for one or the other, or both.